|
Socio-demographics
| | |
|
- Age at baseline, in years
|
1.01 (0.98 – 1.04)
| |
|
- Female gender
|
0.97 (0.59 – 1.58)
| |
|
- Education, in years
|
0.99 (0.92 – 1.05)
| |
|
- No partner
|
1.34 (0.84 – 2.13)
| |
|
- Sampling site
| | |
|
- Amsterdam
|
Ref group
|
Ref group
|
|
- Leiden
|
1.21 (0.65 – 2.25)
|
1.63 (0.81-3.29)
|
|
- Groningen
|
0.78 (0.38 – 1.59)
|
0.95 (0.42-2.11)
|
|
- Apeldoorn/Zutphen
|
0.45 (0.20 – 1.04)
|
0.56 (0.21-1.53)
|
|
- Nijmegen
|
0.73 (0.33 – 1.63)
|
0.81 (0.32-2.06)
|
|
Clinical characteristics at baseline
| | |
|
- First episode MDD
|
0.98 (0.62 – 1.56)
| |
|
- Dysthymia
|
2.03 (1.19 – 3.49)
|
1.30 (0.71-2.37)
|
|
- Onset of depression, in years
|
0.98 (0.97 – 0.995)
|
0.99 (0.98-1.00)
|
|
- Comorbid anxiety disorder
|
1.45 (0.90 – 2.35)
| |
|
- Severity depression symptoms
|
1.06 (1.04 – 1.08)
|
1.05 (1.03-1.07)
|
|
Sampling frame
| | |
|
- Primary care
|
Ref group
|
Ref group
|
|
- Ambulant mental health care
|
0.63 (0.32 – 1.24)
|
0.57 (0.26-1.21)
|
|
- Clinical mental health care
|
0.36 (0.13 – 0.96)
|
0.43 (0.13-1.42)
|
|
- Use anti depressive medication
|
0.88 (0.53 – 1.47)
| |
|
- Use of benzodiazepines
|
1.05 (0.83 – 1.34)
| |
|
Comorbidity at baseline
| | |
|
- Number of chronic diseases
|
1.37 (1.16 – 1.63)
|
1.21 (1.01-1.46)
|
|
- MMSE
|
0.91 (0.80 – 1.04)
| |
